Journal article Open Access

FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF RANOLAZINE EXTENDED RELEASE TABLETS

Alladi saritha and Rebecca Sanjana


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">ranolazine, extended release tablets, Compritol, Carbopol934P</subfield>
  </datafield>
  <controlfield tag="005">20180209154100.0</controlfield>
  <controlfield tag="001">1170150</controlfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">842461</subfield>
    <subfield code="z">md5:19ec7b4609f09e9dbb2f8b26470fd21e</subfield>
    <subfield code="u">https://zenodo.org/record/1170150/files/92.saritha  ranolazine.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2018-02-09</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="o">oai:zenodo.org:1170150</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="c">682-687</subfield>
    <subfield code="n">01</subfield>
    <subfield code="p">INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES</subfield>
    <subfield code="v">05</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Alladi saritha and Rebecca Sanjana</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF RANOLAZINE EXTENDED RELEASE TABLETS</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">http://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;The ranolazine extended release tablets can be prepared by wet granulation method using different polymers in varying combinations. Tablet blends were prepared and micromeritic studies were carried out for those blends and found to be within the limits. Compatability studies were carried out and found that drugs and excipients are compatible with each other. Post compression parameters were carried out found to be within the limits. Also dissolution data of all formulations reveals that as combination of Compritol, Carbopol934P increases the percentage drug release was found to be increased Formulation (F8) containing combination of Compritol, Carbopol934P shows that the 99.5% drug release was found in 24hrs and found similar with that of innovator. On comparing R2 with innovator, formulation (f8) shows similar results with marketed formulation Key words: ranolazine, extended release tablets, Compritol, Carbopol934P&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.1170149</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.1170150</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>
7
31
views
downloads
All versions This version
Views 77
Downloads 3131
Data volume 26.1 MB26.1 MB
Unique views 77
Unique downloads 3030

Share

Cite as